Navigation Links
'Hormone therapy' for food poisoning bacteria

Pathogenic bacteria in the gut recognise their surroundings by detecting hormone signals from the host, which can prompt them to express lethal toxins. Intercepting these hormonal messages could be a better way to treat serious food-borne infections where antibiotics do more harm than good, explains Vanessa Sperandio speaking at the Society for General Microbiology's spring meeting in Edinburgh today.

Gut bacteria, including harmful strains of Escherichia coli and Salmonella that cause food poisoning, detect and respond to adrenaline released by the host, through a sensor called QseC embedded in the bacterial surface. When adrenaline binds to QseC, it is like toppling the first tile of a complex domino arrangement it triggers a chain of events that can ultimately result in the production of toxins.

Dr Sperandio's group at the University of Texas Southwestern Medical Center have identified a molecule, called LED209, which stops adrenaline binding to QseC. Blocking binding prevents the signalling events inside the bacterium, reducing toxin production and also hindering bacteria from attaching effectively to the epithelial cells that line the gut. When given orally to infected mice, LED209 was found to reduce the number of gut-colonising Salmonella.

The discovery could represent the first of a novel class of antimicrobial agents. "QseC is a very attractive drug target because it is present in at least 25 important animal and plant pathogens but not in mammals. This means that drugs targeting this sensor are less likely to be toxic and have the potential to be broad-spectrum (effective against several types of infection)."

Alternative treatments are needed for pathogenic E. coli and Salmonella infections, as antibiotic treatment can make the illness worse, explained Dr Sperandio. "Conventional antibiotics can trigger the SOS response in bacteria that actually enhances virulence. LED209, unlike antibiotics, does not kill or hinder E. coli growth and consequently does not promote expression of shiga toxin - which is the bacterium's defence mechanism. Instead, LED209 decreases expression of genes that encode this toxin," she said. "What is more, because this signalling system does not directly influence bacterial growth, inhibiting it may not exert a strong selective pressure for the development of resistance."


Contact: Laura Udakis
Society for General Microbiology

Related biology news :

1. Circadian clock controls plant growth hormone
2. Study finds Viagra increases release of key reproductive hormone
3. Scientists uncover how hormones achieve their effects
4. Obesity-related hormone is higher in children with Down syndrome
5. Effects of social isolation traced to brain hormone
6. EMD Serono launches easypod, new electronic growth hormone injection device
7. Predicting growth hormone treatment success
8. Human hormone blocker found to help prevent obesity and diabetes: study
9. Research with squirrels provides clues on hormones role in human learning
10. MU researcher links hormone replacement therapy to breast cancer
11. NC State researchers identify genes key to hormone production in plants
Post Your Comments:
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: ) ... provide their customers enhanced security to access and ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology: